Bolstering the liver's immune response to fight off malaria infection

September 27, 2018 by Bob Yirka, Medical Xpress report
The “prime and target” vaccination approach induced TRMs (white arrows) to accumulate in the livers of vaccinated mice after five weeks. Credit: A. Gola et al., Science Translational Medicine (2018)

A team of researchers with members from Oxford University in the U.K., the National Institutes of Health in the U.S. and Leiden University Medical Center in the Netherlands has developed a new approach to battling malaria—boosting an immune response in the liver. In their paper published in the journal Science Translational Medicine, the group describes their approach and how well it worked in mice.

Malaria is a complicated disease caused by a parasite rather than bacteria or a virus, and carried by mosquitoes—it also has a two-stage infection process in its host. Most approaches to fighting the disease involve inoculating a patient with an agent to kill the parasite after it has caused an infection—and sadly, the parasite has started to become resistant to most of them. Because of that, scientists around the world have been working toward a new vaccine, one that in addition to being effective, would not be so easily overcome. In this new approach, the researchers are going after the parasite before it has a chance to reproduce. When a person is bitten by a mosquito, sporozoites enter the bloodstream and make their way to the . Once there, they reproduce asexually, giving birth to multiple merozoites, which go on to infect . The researchers wondered if it might be possible to get the liver to put up more of a response when detecting the presence of sporozoites, killing them before they can reproduce.

To test their idea, the group developed a vaccine that works by activating tissue-resident memory CD8+ T cells in the liver—it makes its way there via a virus-based delivery mechanism. Once there, it remains resident for up to six months. If sporozoites are detected, the T cells activate, killing them.

The researchers report that the approach has worked very well in mice and has thus far been proven to be safe for human use. Next up will be clinical trials to determine if the new vaccine is an effective preventative measure for people living in -endemic regions. They also note that if their method works as hoped, it might also be used to fight other types of infections that get their start in organs such as the liver.

Explore further: Protective antibodies following malaria infection

More information: Anita Gola et al. Prime and target immunization protects against liver-stage malaria in mice, Science Translational Medicine (2018). DOI: 10.1126/scitranslmed.aap9128

Related Stories

Protective antibodies following malaria infection

November 28, 2017
No effective vaccine exists to date against the tropical disease malaria. Scientists from the German Cancer Research Center (DKFZ) have now studied how the human immune system responds to natural infection by the malaria ...

Researchers identify target for novel malaria vaccine

July 13, 2018
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites ...

Major enhancement to in vitro testing of human liver-stage malaria

May 9, 2018
A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver. The liver stage is significant as it precedes the parasite's ability to ...

Study explores new strategy to develop a malaria vaccine

April 11, 2018
A serum developed by Yale researchers reduces infection from malaria in mice, according to a new study. It works by attacking a protein in the saliva of the mosquitos infected with the malaria parasite rather than the parasite ...

Malaria vaccination strategy provides model for superior protection

June 15, 2011
Malaria is a devastating disease caused by the Plasmodium parasite which is transmitted to humans by infected mosquitoes. Hundreds of millions of new cases of malaria are reported each year, and there are more than 750,000 ...

Recommended for you

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.